Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer

NCT04419402 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

162

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Castration-Resistant Prostate Cancer

Interventions

DRUG: Lu-PSMA
DRUG: Enzalutamide

Sponsor

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]